Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Anthony Scott

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
BMC Public Health|March 12, 2021
UK prevalence of underlying conditions which increase the risk of severe COVID-19 disease: a point prevalence study using electronic health recordsJemma L Walker, Daniel J Grint, Helen Strongman, et al.
Lancet (London, England)|June 13, 2006
Pneumococcal vaccination in developing countriesOrin S Levine, Katherine L O'Brien, Maria Knoll, et al.
Vaccine|April 27, 2017
Case-control vaccine effectiveness studies: Data collection, analysis and reporting resultsJennifer R Verani, Abdullah H Baqui, Claire V Broome, et al.
Vaccine|April 27, 2017
Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controlsJennifer R Verani, Abdullah H Baqui, Claire V Broome, et al.
The New England Journal of Medicine|May 21, 2010
CISH and susceptibility to infectious diseasesChiea C Khor, Fredrik O Vannberg, Stephen J Chapman, et al.
The Journal of Infection|January 26, 2025
Global impact of 10- and 13-valent pneumococcal conjugate vaccines on pneumococcal meningitis in all ages: The PSERENADE projectYangyupei Yang, Maria Deloria Knoll, Carly Herbert, et al.
The Lancet. Infectious Diseases|December 20, 2024
Global impact of ten-valent and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in all ages (the PSERENADE project): a global surveillance analysisJulia C Bennett, Maria Deloria Knoll, Eunice W Kagucia, et al.
Microorganisms|April 3, 2021
Changes in Invasive Pneumococcal Disease Caused by <i>Streptococcus pneumoniae</i> Serotype 1 Following Introduction of PCV10 and PCV13: Findings from the PSERENADE ProjectJulia C Bennett, Marissa K Hetrich, Maria Garcia Quesada, et al.
Microorganisms|April 30, 2021
Global Landscape Review of Serotype-Specific Invasive Pneumococcal Disease Surveillance among Countries Using PCV10/13: The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) ProjectMaria Deloria Knoll, Julia C Bennett, Maria Garcia Quesada, et al.
The Lancet. Infectious Diseases|December 20, 2024
Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysisMaria Garcia Quesada, Meagan E Peterson, Julia C Bennett, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
BMC Public Health|March 12, 2021
UK prevalence of underlying conditions which increase the risk of severe COVID-19 disease: a point prevalence study using electronic health recordsJemma L Walker, Daniel J Grint, Helen Strongman, et al.
Lancet (London, England)|June 13, 2006
Pneumococcal vaccination in developing countriesOrin S Levine, Katherine L O'Brien, Maria Knoll, et al.
Vaccine|April 27, 2017
Case-control vaccine effectiveness studies: Data collection, analysis and reporting resultsJennifer R Verani, Abdullah H Baqui, Claire V Broome, et al.
Vaccine|April 27, 2017
Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controlsJennifer R Verani, Abdullah H Baqui, Claire V Broome, et al.
The New England Journal of Medicine|May 21, 2010
CISH and susceptibility to infectious diseasesChiea C Khor, Fredrik O Vannberg, Stephen J Chapman, et al.
The Journal of Infection|January 26, 2025
Global impact of 10- and 13-valent pneumococcal conjugate vaccines on pneumococcal meningitis in all ages: The PSERENADE projectYangyupei Yang, Maria Deloria Knoll, Carly Herbert, et al.
The Lancet. Infectious Diseases|December 20, 2024
Global impact of ten-valent and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in all ages (the PSERENADE project): a global surveillance analysisJulia C Bennett, Maria Deloria Knoll, Eunice W Kagucia, et al.
Microorganisms|April 3, 2021
Changes in Invasive Pneumococcal Disease Caused by <i>Streptococcus pneumoniae</i> Serotype 1 Following Introduction of PCV10 and PCV13: Findings from the PSERENADE ProjectJulia C Bennett, Marissa K Hetrich, Maria Garcia Quesada, et al.
Microorganisms|April 30, 2021
Global Landscape Review of Serotype-Specific Invasive Pneumococcal Disease Surveillance among Countries Using PCV10/13: The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) ProjectMaria Deloria Knoll, Julia C Bennett, Maria Garcia Quesada, et al.
The Lancet. Infectious Diseases|December 20, 2024
Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysisMaria Garcia Quesada, Meagan E Peterson, Julia C Bennett, et al.
Pageof 2